Mural Oncology plc (MURA) — Financial Flexibility Index

Latest as of September 2025: -1.75x

Mural Oncology plc (MURA) has a Financial Flexibility Index of -1.75x as of September 2025. Free cash flow of $-18.48 Million (operating CF $-18.48 Million minus capex $0.00) represents -2% of total liabilities ($10.57 Million). Check Mural Oncology plc tangible equity quality to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

-1.75x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-18.48 Million
Operating CF − Capex

Total Liabilities

$10.57 Million
USD

Capital Expenditures

$0.00
USD

Mural Oncology plc Financial Flexibility Index (2021–2024)

Historical Financial Flexibility Index trend for Mural Oncology plc across 4 annual periods. For the full cash flow conversion analysis, see MURA operating cash flow.

Annual Financial Flexibility Index for Mural Oncology plc (2021–2024)

Year-by-year free cash flow to debt coverage for Mural Oncology plc. Explore MURA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -4.45x $-128.45 Million $-128.54 Million $28.89 Million ▲ +11.6%
2023 -5.03x $-190.80 Million $-194.25 Million $37.93 Million ▼ -70.9%
2022 -2.94x $-163.08 Million $-168.59 Million $55.41 Million ▼ -2.4%
2021 -2.87x $-152.28 Million $-156.67 Million $52.99 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities